|4Feb 20, 8:41 PM ET

Endicott David J. 4

4 · ALLERGAN INC · Filed Feb 20, 2013

Insider Transaction Report

Form 4
Period: 2013-02-15
Endicott David J.
CVP and President, AGN Med US
Transactions
  • Tax Payment

    Common Stock

    2013-02-15$108.02/sh225$24,30520,129 total
Holdings
  • Common Stock

    (indirect: By Trust)
    3,113.565
Footnotes (2)
  • [F1]Exempt disposition to the issuer, effective 2/15/2013, transaction date, of a number of shares determined to be sufficient to satisfy tax withholding obligations resulting from the lapse of restrictions of an exempt award of 609 shares of restricted stock granted on 2/17/2011.
  • [F2]Shares allocated to the reporting person's ESOP account as of reporting date.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT